944.8000 18.55 (2.00%)
NSE Jun 13, 2025 15:31 PM
Volume: 53,126
 

944.80
2.00%
KRChoksey
For Q3FY24, TATVA revenue was INR 842 Mn which declined by 30.2% YoY and 12.9% QoQ. This significant decline was due to continued subdued demand for the specialty chemical industry and financial year-end for global end customers.
Tatva Chintan Pharma Chem Ltd. is trading above all available SMAs
More from Tatva Chintan Pharma Chem Ltd.
Recommended